Zobrazeno 1 - 10
of 36
pro vyhledávání: '"José Miguel Senabre-Gallego"'
Autor:
Francisca Sivera, Victoria Núñez-Monje, Cristina Campos-Fernández, Isabel Balaguer-Trull, Montserrat Robustillo-Villarino, Marta Aguilar-Zamora, Marta Garijo-Bufort, Juan Miguel López-Gómez, Carolina Peña-González, Isabel de la Morena, Diego Bedoya-Sanchís, Liliya Yankova-Komsalova, Arantxa Conesa-Mateos, Anna Martínez-Cristóbal, Francisco Javier Navarro-Blasco, José Miguel Senabre-Gallego, Juan José Alegre-Sancho
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundSecukinumab is a biologic disease-modifying antirheumatic drug (bDMARD) that has demonstrated efficacy in the treatment of axial spondyloarthritis (axSpA, i.e., ankylosing spondylitis and non-radiographic axSpA) across various clinical tria
Externí odkaz:
https://doaj.org/article/9a3bf1cebdbb4988b66a96731004b8e1
Autor:
Ana Pons Bas, Grupo Aire-Mb, G. Santos-Soler, José Rosas, José Antonio Bernal, José Miguel Senabre-Gallego
Publikováno v:
Reumatología Clínica. 18:188-189
Autor:
José, Rosas, José Miguel, Senabre-Gallego, Gregorio, Santos-Soler, José Antonio, Bernal, Ana, Pons Bas
Publikováno v:
Reumatologia clinica. 18(3)
Autor:
J. Molina, Antonio Vela Pons, Xavier Barber, José Rosas, G. Santos Soler, J. A. Bernal, José Miguel Senabre-Gallego, Clímaco Cano, M. Marco, J. A. García-Gómez
Publikováno v:
Annals of the Rheumatic Diseases. 79:736-737
Background:Production of anti-drug antibodies (ADA) could cause low serum anti-TNF levels and low drug retention rates.Objectives:To assess the relationship between serum adalimumab (ADL) levels and drug retention rates in patients with axial SpA.Met
Autor:
A. Pons, Gregorio Santos Soler, E. Ivars, Xavier Barber, José Rosas, Aire-Mb, José Antonio Bernal-Vidal, José Miguel Senabre-Gallego, Esteban Salas-Heredia, C. Cano, José Alberto García-Gómez
Publikováno v:
Abstracts Accepted for Publication.
Objectives To know the characteristics of patients with rheumatoid arthritis (RA), in treatment with baricitinib (BARI), who have failed to conventional synthetic DMARD (DMARDcs) and/or biological DMARDs (DMARD). Methods Prospective observational stu
Autor:
José Miguel Senabre-Gallego, Isabel de la Morena, M. Aguilar-Zamora, D. Ybáñez-García, C Vergara-Dangond, J. J. Alegre-Sancho, M. Robustillo-Villarino, María Dolores García-Armario, J. Lluch Pons, J Fiter-Areste, Vega Jovani, I. Vázquez-Gómez, VNúñez Monje, A. Sendra-García, I Torner-Hernández, Ana Urruticoechea-Arana, S Antón-González, L. Montolio-Chiva, A Martínez-Cristóbal, Elia Valls-Pascual, L Gómez Escolar, À. Martínez-Ferrer, Lourdes Mateo, Jm Paredes Arquiola, Meritxell Fernández Matilla, D Reina-Sanz, Ana V Orenes Vera, C. Fernández, Sergi Ordoñez
Publikováno v:
Epidemiology, risk factors for disease or disease progression.
Background Patients with chronic inflammatory disease in treatment with immunosuppressants have an increased risk of opportunistic infections, including leishmaniasis. Objectives To describe a multicenter case series of leishmaniasis in patients with
Autor:
José Rosas, Aire-Mb, C. Cano, José Alberto García-Gómez, Gregorio Santos Soler, Esteban Salas-Heredia, E. Ivars, Xavier Barber, José Miguel Senabre-Gallego, José Antonio Bernal-Vidal, A. Pons
Publikováno v:
Saturday, 15 June 2019.
Objectives To know risk of admission due to infection in patients treated with biological drugs (DMARDb). Methods Case-control study, in patients admitted for infection, treated with DMARDb, from 2000-2018. As a control group, patients included, in t
Autor:
Gregorio Santos Soler, E. Ivars, A. Pons, José Antonio Bernal-Vidal, C. Cano, Esteban Salas-Heredia, Xavier Barber, José Rosas, Aire-Mb, José Miguel Senabre-Gallego, José Alberto García-Gómez
Publikováno v:
Abstracts Accepted for Publication.
Objectives To know the impact of obesity on the risk of fracture. Methods Observational study, during 2010-2018, of patients referred for bone densitometry (BMD), to the Bone Densitometry Unit of Rheumatology. BMD performed by Rheumatology nursing, c
Autor:
Juan José Alegre-Sancho, Victoria Núñez-Monje, Cristina Campos-Fernández, Isabel Balaguer-Trull, Montserrat Robustillo-Villarino, Marta Aguilar-Zamora, Marta Garijo-Bufort, Teresa Pedraz-Penalva, Carolina Peña-González, Isabel de la Morena, Diego Bedoya-Sanchís, Liliya Yankova-Komsalova, Arantxa Conesa-Mateos, Anna Martinez-Cristóbal, Francisco Javier Navarro-Blasco, Jose Miguel Senabre-Gallego, Francisca Sivera
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionPsoriatic arthritis (PsA) is a complex and heterogeneous inflammatory disease. Secukinumab, a biologic disease-modifying antirheumatic drug (bDMARD), has extensive clinical evidence of efficacy and safety in the treatment of PsA but data
Externí odkaz:
https://doaj.org/article/58e88dcc8c904735afa8ecbe0e57ec57
Autor:
José Rosas, J. A. Bernal, G. Santos Soler, Antonio Vela Pons, Xavier Barber, José Miguel Senabre-Gallego, M. Lorente Betoret, J. A. García-Gómez, Clímaco Cano
Publikováno v:
Annals of the Rheumatic Diseases. 79:186.2-186
Background:Discontinuation of denosumab treatment causes an increase in bone resorption that has been linked to the emergence of vertebral fractures.Objectives:To evaluate the association of clinical features and demographic characteristics with the